Giá hiện tại
Niki BioSolutions, Inc., is a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases.
e.g. Promoter holding
Loading chart...
Dự báo EPS và doanh thu theo đồng thuận của các nhà phân tích.
| Metric (B) | FY 2023 |
|---|---|
| — | |
| 0 | |
| — |
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AAzora Ther... | AZR | $58.43M | — | 3.53 | — | — | — | — |
| 2. | KKiora Phar... | KPRX | $5.44M | — | 0.32 | — | — | -56.40% | — |
| 3. | SSynlogic I... | SYBX | $7.72M | — | 0.62 | — | — | -8.17% | -100.00% |
| 4. | PPsyence Bi... | PBM | $12.00M | — | 0.71 | — | — | -58.60% | — |
| 5. | AAptorum Gr... | APM | $570,060 | — | 0.25 | — | — | -10.80% | -100.00% |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Quarter (M) | Jun 22 | Mar 23 | Sep 23 | Mar 24 | Sep 24 | Dec 24 | Sep 25 | Dec 25 |
|---|---|---|---|---|---|---|---|---|
Revenue | 0.53 | 0.77 | 0.43 | 0 | 0 | 0 | 0 | 0 |
COGS | 1.11 | 1.31 | 1.1 | 0.45 | 0.26 | 0 | 0 | 0 |
Gross Profit | -0.58 | -0.54 | -0.67 | -0.46 | -0.26 | 0 | 0 | 0 |
Gross Profit % | -110.91% | -70.53% | -154.16% | - | - | - | - | - |
| 7.87 | 8.52 | 5.87 | 3.54 | 2.47 | -0.56 | 0.59 | 0.83 | |
EBIT | -8.45 | -9.06 | -6.54 | -3.99 | -2.87 | 0.56 | -0.4 | -0.83 |
OPM % | -1602.39% | -1178.77% | -1515.84% | - | - | - | - | - |
Non-Operating Income | 5.72 | 0.26 | -0.07 | 0 | 0 | -1.33 | -0.21 | 0.51 |
PBT | -2.73 | -8.79 | -6.61 | 2.26 | -2.66 | -0.77 | -0.62 | -0.31 |
Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Rate % | - | - | - | - | - | - | - | - |
Net Income | -1.89 | -7.91 | -5.49 | 2.66 | -2.64 | -0.92 | -0.61 | -0.31 |
NPM % | -357.37% | -1029.9% | -1271.97% | - | - | - | - | - |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Period (M) | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 0 | 0.38 | 0.54 | 0.91 | 1.54 | 1.3 | 0.43 | 0 | 0 |
COGS | 0.06 | 0.32 | 0.79 | 1.01 | 1.46 | 1.22 | 0.42 | 0.26 | 0 |
Gross Profit | -0.06 | 0.07 | -0.26 | -0.1 | 0.08 | 0.08 | 0.01 | -0.26 | 0 |
Gross Profit % | - | 17.07% | -48.4% | -11.41% | 5.31% | 6.18% | 2.45% | - | - |
| 5.63 | 10.39 | -0.26 | 20.17 | 19.29 | 17.25 | 10.61 | 3.54 | 1.82 | |
EBIT | -5.69 | -10.33 | -18.2 | -19.89 | -19.21 | -17.51 | -10.6 | -3.8 | -1.82 |
OPM % | - | -2693.44% | -3400.44% | -2182.63% | -1245.59% | -1351.01% | -2457.47% | - | - |
Non-Operating Income | 0 | -4.81 | -1.92 | 24.81 | -7.91 | 5.98 | 6.26 | -0.36 | 0.44 |
PBT | -2.56 | -15.13 | -20.12 | 4.92 | -27.11 | -11.53 | -4.34 | -4.16 | -1.38 |
Income Tax | -0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Rate % | 0.55% | - | - | - | - | - | - | - | - |
Net Income | -2.55 | -14.83 | -18.69 | 7.07 | -25.05 | -9.8 | -2.83 | -4.27 | -1.36 |
NPM % | - | -3868.04% | -3491.81% | 775.31% | -1624.38% | -756.17% | -654.88% | - | - |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Period (M) | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 16.25 | 12.01 | 5.19 | 3.5 | 8.13 | 1.88 | 2.01 | 0.87 | 3.45 | |
| 1.97 | 1.01 | 1.06 | 28.38 | 0.24 | 9.85 | 16.1 | 15.1 | 15.1 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 2.03 | 15.56 | 1.78 | 1.78 | 4.19 | 5.08 | 0.47 | 0.09 | 0.14 | |
| 11.31 | 16.5 | 15.92 | 10.57 | 9.35 | 4.05 | 2.07 | 0.07 | 0 | |
Total Assets | 31.56 | 45.07 | 23.95 | 44.23 | 21.91 | 20.87 | 20.64 | 16.13 | 18.69 |
| 27.86 | 28.98 | 29.04 | 34.02 | 35.64 | 35.71 | 0 | 0 | 0 | |
| 2.38 | 4.14 | -12.67 | 7.81 | -12.03 | -20 | 24.85 | 21.13 | 23.16 | |
| 0.48 | 10.3 | 6.47 | 3.32 | 0.22 | 6.85 | 3.28 | 3.35 | 3.44 | |
| 0.85 | 2.03 | 2.63 | 2.76 | 3.98 | 6.18 | 1.97 | 1 | 1.15 | |
| 0 | 0 | 0 | 0 | 0.2 | 0 | 0 | 0 | 0.31 | |
Total Liabilities | 31.57 | 45.44 | 25.46 | 47.91 | 28.01 | 28.75 | 30.1 | 25.49 | 28.06 |
Số liệu hợp nhất (triệu) / Có thể xem riêng lẻ
| Period (M) | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -5.78 | -10.04 | 0 | 0 | 0 | -12.32 | -7.72 | -1.19 | -1.84 | |
| 12.8 | -6.06 | 0 | 0 | 0 | 2.44 | 0.62 | 0.06 | 0 | |
| 9.08 | 25.48 | 0 | 0 | 0 | 6.63 | 4.09 | 0 | 4.42 | |
Net CFNet Cash Flow | 16.1 | 9.38 | 0 | 0 | 0 | -3.25 | -3.01 | -1.13 | 2.58 |
FCFFree Cash Flow | -8.84 | -16.1 | 0 | 0 | 0 | -12.51 | -7.73 | -1.19 | -1.84 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| - | -46.8% | -75.5% | 24.3% | -76.6% | -49.8% | -13.9% | -18.6% | -6.2% | |
| 0.02 | 0.31 | 0.40 | 0.08 | 0.01 | 0.44 | 0.13 | 0.16 | 0.15 | |
| 15.24 | 2.36 | 3.00 | 8.70 | 2.90 | 0.57 | 1.18 | 0.22 | 0.78 | |
| - | 0.01 | 0.02 | 0.03 | 0.05 | 0.06 | 0.02 | 0.00 | 0.00 | |
Cash Conversion | 2.27 | 0.68 | - | - | - | 1.26 | 2.73 | 0.28 | 1.35 |
Payout Ratio | - | - | - | - | - | - | - | - | - |
| - | - | 39.6% | 70.3% | 69.2% | -16.0% | -66.7% | -100.0% | - | |
| - | - | - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | - | - | |
| 2.00 | 2.00 | 3.00 | 5.00 | 3.00 | 1.00 | 3.00 | 2.00 | 3.00 | |
| - | - | -6.20 | -1.64 | -3.89 | -3.10 | -1.75 | - | - | |
| 50.00 | 26.67 | 26.67 | 60.00 | 33.33 | 26.67 | 33.33 | 50.00 | 50.00 | |
| - | -38.7% | -34.9% | 7.8% | -16.2% | -7.6% | -6.5% | - | - |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Ai sở hữu Aptorum Group Ltd, theo hồ sơ SEC
Schedule 13D / 13G filers (5%+), plus stakes Aptorum Group Ltd holds in others · open a holder to see each filing
| Holder | Type | Based in | Shares | % of class | Latest filing |
|---|---|---|---|---|---|
| Non-US institution | E9 | 0 | 0.00% | SC 13G/A · 15 May 2025 | |
| Corporation | E9 | 0 | 0.00% | SC 13G · 10 Jan 2025 |
Anyone owning more than 5% must file a Schedule 13D (active) or 13G (passive). Structured filings since December 2024; a holder that drops below 5% files an exit amendment. 13F still covers them in the shareholding table.
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 30 Oct 2026 | 1,717 | -70.1% | 1.00 | |
| 15 Oct 2026 | 5,751 | -60.6% | 1.00 | |
| 30 Sep 2026 | 14,602 | +11.4% | 1.00 | |
| 15 Sep 2026 | 13,110 | +377.6% | 1.00 | |
| 31 Aug 2026 | 2,745 | -36.4% | 1.00 | |
| 14 Aug 2026 | 4,315 | -82.6% | 1.00 | |
| 31 Jul 2026 | 24,793 | -63.0% | 1.00 |
FINRA consolidated short interest, reported twice a month for every US listing.
Hồ sơ SEC và bản ghi cuộc gọi kết quả kinh doanh của Aptorum Group Ltd
What recent news says about Aptorum Group Ltd, scored for sentiment.